Xandr Universal Pixel

Indicaid™ COVID-19 Rapid Antigen Test (25 individual tests)

PHASE Scientific International, Ltd.
SKU: RD3-c

$253.99 per box of 25 tests

Indicaid helps healthcare providers test Individuals at Point of Care who are showing symptoms of Covid-19 by providing the latest screening available against Covid-19 and its variants at reasonable cost because unlike any other Clinical Diagnostics marketplace, Meenta offers convenient, unfettered access to validated tests.

In stock

Indicaid helps healthcare providers test Individuals at Point of Care who are showing symptoms of Covid-19 by providing the latest screening available against Covid-19 and its variants at reasonable cost because unlike any other Clinical Diagnostics marketplace, Meenta offers convenient, unfettered access to validated tests.

The Fine Print

Fast, Easy, Comfortable. The Indicaid Covid-19 rapid antigen test is authorized for professional use by the FDA (EUA) in point-of-care settings by organizations with CLIA certification . With visual results in 15 minutes and lower nasal swab collection, Indicaid is fast and comfortable for patient.  There are 25 tests in this box.

General Details:

  • Test type: Antigen
  • Run time: 15 minutes
  • Collection type: Lower nasal swab
  • Authorization: FDA EUA for home and over-the-counter use. No CLIA certification required.
  • Intended Use: Lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid protein.
  • Manufacturer: PHASE Scientific International, Ltd.
  • CPT Codes: Covid-19 87811QW

Clinical Details:

  • SARS-CoV-2: 94% Sensitivity, 98% Specificity (Self-Collected)
  • Specificity: No cross-reaction with species tested
  • Interference: No interfering factors tested

Box Components:

  • Test devices (2)
  • Nasal collection swabs (2)
  • Solution vial (2)
  • Instructions For Use (1)

Storage and Handling:

Test kits should be stored at 2-30°C (35-86°F). Reagents and materials are stable until the expiration date printed on the outer packaging. Do not use beyond the expiration date. The test device must remain in the sealed pouch until use. Do not freeze any contents of the kit.
When do I need to test again (serial testing)?

A negative test result does not rule out infection but repeat testing over two or three days may decrease the risk of false negative results. An initial negative test result should be the first of a minimum of two tests. An asymptomatic individual undergoing serial testing with two or more negative results may require ongoing serial testing or confirmatory testing, depending on patient history and potential exposures. An asymptomatic individual undergoing serial testing with one or more positive results indicates that SARS-CoV-2 antigen is present, but does not rule out infection with other pathogens.

What is an EUA?

What is an EUA? The United States FDA has made this test available under an emergency access mechanism called an Emergency Use Authorization (EUA). The EUA is supported by the Secretary of Health and Human Services (HHSs) declaration that circumstances exist to justify the emergency use of in vitro diagnostics (IVDs) for the detection and/or diagnosis of the virus that causes COVID-19. An IVD made available under an EUA has not undergone the same type of review as an FDA-approved or cleared IVD. FDA may issue an EUA when certain criteria are met, which includes that there are no adequate, approved, available alternatives, and based on the totality of scientific evidence available, it is reasonable to believe that this IVD may be effective in diagnosing COVID-19.

Nasal swab

  • No products in the cart.